Drug Type CAR-T |
Synonyms CI9 cells |
Target |
Action modulators |
Mechanism CCR9 modulators(C-C chemokine receptor type 9 modulators), CXCR4 modulators(C-X-C motif chemokine receptor 4 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| T-cell Acute Lymphoblastic Leukemia/Lymphoma | Preclinical | China | 03 Nov 2025 |





